Abstract
The efficacy of NSAIDs in many rheumatological indications, for analgesic and anti-inflammatory purposes, is no longer in question. However, their prescription may be hindered by co-morbidities that could be aggravated by these drugs, such as coronary artery disease, chronic renal failure or a history of bleeding gastric ulcers. This article provides an update on preventive measures to avoid these complications.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
